Singapore: The US FDA's Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted unanimously in support o...
Japanese pharmaceutical giant Chugai Pharmaceutical Co Ltd has announced that its Actemra Subcutaneous Injection (Actemr...
Prosetta Biosciences Inc. has entered into a Feasibility and First Right of Negotiation Agreement with Japan's Takeda Ph...
Pharma Major Lupin announced that its US subsidiary, Gavis Pharmaceuticals LLC., (collectively Lupin) has received final...
Singapore: GlobalData's analysis shows that the global gout therapeutics market grew at a compound annual growth rate (...
Singapore: US-based Repligen has entered into an exclusive worldwide licensing agreement with Pfizer to advance Repligen...
Singapore: United Kingdom (UK) has committed to contrbute $1.6 billion to fight AIDS, Tuberculosis and Malaria. Ms Just...
Singapore: China based biotech firm developing targeted and immune-oncology therapeutics, BeiGene, has raised $75 millio...
Singapore: Johns Hopkins University's Institute for Applied Economics, Global Health and the Study of Business Enterpris...
Bangalore: Suven Life Sciences received three product patents one each from Canada (2600271), China (CN 101544592B) and ...
Singapore: US Food and Drug Administration has raised alarm for Gilead Science's cancer medicine Zydelig (idelalisib) du...
Singapore: US-based CytRx, a biopharmaceutical R&D company specializing in oncology, reached an agreement with the U...
Singapore: China based Zai Lab, an innovative biopharmaceutical company, has secured over $100 million in Series B finan...
Singapore: Australian company CSL Behring has submitted a variation application to the European Medicines Agency (EMA) f...
Singapore: Taiwan company Orient Europharma and Japan-based pharmaceutical company NanoCarrier have signed a new agreeme...
US-Australian drug discovery company, Novogen Limited has provided an update on progress regarding the development of Ca...
Tokyo: Toxoplasma gondii is a common parasite which causes the development of fatal encephalosis or pneumonia in immunod...
Tokyo: Gordagen Pharmaceuticals, an Australian company developing evidence-based nutraceuticals and pharmaceuticals, has...
